Laurie Glimcher
Physician
>
/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/ZJEC7EZPXNS6UPKXBEPTTNYSUU.jpg&imgrefurl=https://www.bostonglobe.com/2023/12/09/business/dana-farber-ceo-laurie-glimcher-has-always-been-trailblazer-risk-taker/&h=867&w=1440&tbnid=3RQdgPhpjUu0tM&q=Laurie+Glimcher&tbnh=90&tbnw=150&usg=AI4_-kRKHJdvHREyX4Z8Jh7GQziYDXoIsg&vet=1&docid=60ljELXLBlw6zM&hl=en&sa=X&ved=2ahUKEwjP0oDLzcuGAxVulYkEHZYoLeAQ9QF6BAgIEAo)
Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019. Wikipedia
Spouse: Gregory A. Petsko
Children: Jake Auchincloss
Grandchild: Teddy Auchincloss
Parents: Melvin J. Glimcher
People also ask
How old is Laurie Glimcher?
How much does the CEO of Dana-Farber make a year?
Who is Dr Laurie Glimcher CEO?
Who is the head of the Dana-Farber Oncology Program?
Learn about Laurie Glimcher's leadership and vision as President and CEO of Dana-Farber, a world-renowned cancer treatment and research center.
Laurie Hollis Glimcher (born 1951) is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016.
Laurie H. Glimcher, MD, is the President and CEO of the Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard Cancer Center, and the Richard and ...
Laurie H. Glimcher, M.D., was named president and CEO of Dana-Farber Cancer Institute in 2016. She is also director of the Dana-Farber/Harvard Cancer Center ...
President and CEO, Dana-Farber Cancer Institute; Richard and Susan Smith Professor of Medicine, Harvard Medical School · Industry · Location · More in Medicine.
Biography. Laurie H. Glimcher is the president and chief executive officer of the Dana-Farber Cancer Institute and also serves as chief executive officer of ...
Human T-bet Governs Innate and Innate-like Adaptive IFN-? Immunity against Mycobacteria. Cell. 2020 12 23; 183(7):1826-1847.e31. PMID: 33296702; PMCID: ...
Dr.Glimcher is widely considered to be a world leader in understanding the transcriptional regulation of the cellular differentiation pathways in lymphocytes.
Weill Cornell Medical College and drug maker UCB have teamed up to translate innovative Weill Cornell-led research in bone disorders, metabolic disease and ...